Illumina Leads $8M Financing Round in GenoLogics | GenomeWeb

Laboratory information management system software company GenoLogics said last week that it has closed an $8 million funding round led by Illumina, a new investor in the company.

The financing will be used to develop products for clinical applications and new desktop sequencing systems, and also to expand sales and marketing functions. As part of the deal, Illumina's senior vice president and chief commercial officer, Tristan Orpin, will join GenoLogics' board of directors.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.